Tag:
Cell Biosciences
Latest Headlines
Latest Headlines
Cell Biosciences inks deal for Alpha Innotech
Cell Biosciences is buying Alpha Innotech for $1.50 per share, or about $17.9 million in cash. The acquisition expands Cell Biosciences' protein analysis business. "This strategic acquisition marks
Cell Biosciences pockets $10 million in third round
The Wellcome Trust led a $10 million Series C round for Cell Biosciences, a Palo Alto-based provider of nanoproteomic analysis systems to life science researchers. The Cell Biosciences platform is a
